Annual Non Current Assets
$49.29 M
-$543.00 K-1.09%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual long term assets is $49.29 million, with the most recent change of -$543.00 thousand (-1.09%) on March 1, 2024.
- During the last 3 years, GRCE annual non current assets has risen by +$49.20 million (+57213.95%).
- GRCE annual non current assets is now -40.86% below its all-time high of $83.34 million, reached on March 1, 2022.
Performance
GRCE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$49.29 M
-$2000.000.00%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly long term assets is $49.29 million, with the most recent change of -$2000.00 (0.00%) on September 1, 2024.
- Over the past year, GRCE quarterly non current assets has dropped by -$14.00 thousand (-0.03%).
- GRCE quarterly non current assets is now -41.10% below its all-time high of $83.68 million, reached on June 1, 2022.
Performance
GRCE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
GRCE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -0.0% |
| 3 y3 years | +10000.0% | -40.9% |
| 5 y5 years | +452.0% | +547.8% |
GRCE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.9% | >+9999.0% | -41.1% | at low |
| 5 y | 5-year | -40.9% | >+9999.0% | -41.1% | >+9999.0% |
| alltime | all time | -40.9% | >+9999.0% | -41.1% | >+9999.0% |
Grace Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.29 M(-0.0%) |
| Jun 2024 | - | $49.29 M(-0.0%) |
| Mar 2024 | $24.01 M(-18.0%) | $49.29 M(-0.0%) |
| Dec 2023 | - | $49.30 M(-0.0%) |
| Sep 2023 | - | $49.32 M(-0.2%) |
| Jun 2023 | - | $49.42 M(-0.8%) |
| Mar 2023 | $29.29 M(-35.3%) | $49.83 M(-40.2%) |
| Dec 2022 | - | $83.37 M(-0.0%) |
| Sep 2022 | - | $83.41 M(-0.3%) |
| Jun 2022 | - | $83.68 M(+0.4%) |
| Mar 2022 | $45.28 M(-27.4%) | $83.34 M(+27.8%) |
| Dec 2021 | - | $65.23 M(-0.0%) |
| Sep 2021 | - | $65.25 M(>+9900.0%) |
| Jun 2021 | - | $66.00 K(-23.3%) |
| Mar 2021 | $62.37 M(+237.8%) | $86.00 K(-18.1%) |
| Dec 2020 | - | $105.00 K(-11.8%) |
| Sep 2020 | - | $119.00 K(-98.1%) |
| Jun 2020 | - | $6.18 M(+40.7%) |
| Mar 2020 | $18.46 M(-34.0%) | $4.39 M(-38.1%) |
| Dec 2019 | - | $7.10 M(-6.7%) |
| Sep 2019 | - | $7.61 M(-4.3%) |
| Jun 2019 | - | $7.95 M(-11.0%) |
| Mar 2019 | $27.97 M(+280.5%) | $8.93 M(+2.0%) |
| Dec 2018 | - | $8.75 M(-9.9%) |
| Sep 2018 | - | $9.72 M(-2.2%) |
| Jun 2018 | - | $9.94 M(-4.7%) |
| Mar 2018 | $7.35 M(-4.7%) | $10.43 M(-5.9%) |
| Dec 2017 | - | $11.08 M(-1.2%) |
| Sep 2017 | - | $11.21 M(+0.2%) |
| Jun 2017 | - | $11.18 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $7.71 M(-7.8%) | - |
| Nov 2016 | - | $11.47 M(-0.1%) |
| Aug 2016 | - | $11.48 M(-12.5%) |
| May 2016 | - | $13.11 M(+3.4%) |
| Feb 2016 | $8.36 M(-46.8%) | $12.69 M(+5.1%) |
| Nov 2015 | - | $12.07 M(-3.8%) |
| Aug 2015 | - | $12.54 M(-9.2%) |
| May 2015 | - | $13.81 M(-1.6%) |
| Feb 2015 | $15.70 M(-32.3%) | $14.04 M(-11.3%) |
| Nov 2014 | - | $15.84 M(-7.9%) |
| Aug 2014 | - | $17.20 M(-3.0%) |
| May 2014 | - | $17.73 M(-0.4%) |
| Feb 2014 | $23.20 M(+305.4%) | $17.81 M(-6.4%) |
| Nov 2013 | - | $19.02 M(-3.7%) |
| Aug 2013 | - | $19.74 M(+229.9%) |
| May 2013 | - | $5.98 M(-2.9%) |
| Feb 2013 | $5.72 M(-35.7%) | $6.16 M(-4.2%) |
| Nov 2012 | - | $6.44 M(-2.4%) |
| Aug 2012 | - | $6.59 M(+1.3%) |
| May 2012 | - | $6.51 M(-5.9%) |
| Feb 2012 | $8.91 M(+164.8%) | $6.91 M(+1.4%) |
| Nov 2011 | - | $6.82 M(-7.4%) |
| Aug 2011 | - | $7.36 M(-2.5%) |
| May 2011 | - | $7.55 M(-2.1%) |
| Feb 2011 | $3.36 M(+288.2%) | $7.71 M(>+9900.0%) |
| Nov 2010 | - | $34.00 K(-4.2%) |
| Aug 2010 | - | $35.50 K(+23.3%) |
| May 2010 | - | $28.80 K(-99.6%) |
| Feb 2010 | $866.70 K | $8.03 M(>+9900.0%) |
| Nov 2009 | - | $16.90 K |
FAQ
- What is Grace Therapeutics annual long term assets?
- What is the all time high annual non current assets for Grace Therapeutics?
- What is Grace Therapeutics annual non current assets year-on-year change?
- What is Grace Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Grace Therapeutics?
- What is Grace Therapeutics quarterly non current assets year-on-year change?
What is Grace Therapeutics annual long term assets?
The current annual non current assets of GRCE is $49.29 M
What is the all time high annual non current assets for Grace Therapeutics?
Grace Therapeutics all-time high annual long term assets is $83.34 M
What is Grace Therapeutics annual non current assets year-on-year change?
Over the past year, GRCE annual long term assets has changed by -$543.00 K (-1.09%)
What is Grace Therapeutics quarterly long term assets?
The current quarterly non current assets of GRCE is $49.29 M
What is the all time high quarterly non current assets for Grace Therapeutics?
Grace Therapeutics all-time high quarterly long term assets is $83.68 M
What is Grace Therapeutics quarterly non current assets year-on-year change?
Over the past year, GRCE quarterly long term assets has changed by -$14.00 K (-0.03%)